NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I'm excited to see the results. I also think they will be dong analyses that they did not previously do, based on the latest science. IF they break out the Mesenchymal type GBM patients, which were the ones least likely to survive, previously, I suspect they will have very good results.

I think they will very likely find excellent results if they break the patients out into the main types of GBM tumors. And in that context, that also may have been what they've been discussing with various regulators during this time.

Just my opinion.